Shanghai Pharmaceuticals Holdings Co. Ltd. on Thursday announced a cooperation deal with DXY, one of China's largest online pharmaceutical platforms.

According to the agreement, Shanghai Pharma's e-commerce subsidiary will become DXY clinics' only pharmaceutical supplier, while DXY will help provide better e-clinic services.

By the end of 2014, DXY had 4.5 million registered users, all medical, pharmaceutical and life science professionals.

Shanghai Pharma's principal business covers pharmaceutical R&D, manufacturing, distribution and retail.

The cooperation deal will provide faster, cheaper and more convenient services, according to a Shanghai Pharma representative.